Ramelteon Prevention of Delirium - RCT

Status unconfirmed · Phase 4 · Has a placebo group

Conditions studied: Delirium

In brief

Delirium is a common morbid condition in hospitalized adults. Treatment of delirium has been unsatisfactory and prevention is the preferred goal. Based on limited experimental research, ramelteon appears to have promise for prevention. This study will evaluate ramelteon in prevention of delirium in a hospitalized adult population age 65+ in a double-blinded RCT.

Key facts

Study ID

NCT02564939

Run by

Hartford Hospital

People needed

240

Starts

2017-02-23

Expected to finish

2019-06-01

Last updated by the study team

2018-08-01

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• from designated nursing units

Where it is running

• Hartford Hospital — Hartford, Connecticut, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.